Sociedad Americana de Hirudoterapia

Current concepts in salvage procedures for failing microvascular flaps: is there a superior technique? Insights from a systematic review of the literature

Troeltzsch M, Troeltzsch M, Probst FA, Ristow O, Ehrenfeld M, Otto S (2016) · International Journal of Oral and Maxillofacial Surgery · n=330

Detalle de evidencia de RCTReferencia del ensayo
GRADE bajaCohorte / serie de casos
Tamaño de muestra de este ensayo en comparación con otros ensayos de venous-congestion-flapMarquard JM 20251215Bishop JL 2023843Doğan S 2024570Troeltzsch M 2016330Kucur C 2015260Wang ZD 2022210Lehnhardt M 202196Kruer RM 201459Mozafari N 201056Merlino G 202048
Este ensayo (destacado) por tamaño de muestra junto a otros ensayos indexados de venous-congestion-flap. Los ensayos más grandes generalmente tienen mayor peso estadístico.

Perfil del estudio

Diseño
systematic review of 39 studies (330 microvascular free flap salvage cases) published between 1990 and 2015, with predefined inclusion/exclusion criteria and pooled descriptive analysis of salvage techniques; 11 leech-therapy studies (73 flaps) included (LMU Munich, University Goettingen, University Heidelberg)
Tamaño de la muestra (n)
330
Intervención
Comparative assessment across four primary salvage techniques: (1) Fogarty catheter thrombectomy (6 studies, 68 flaps), (2) intraoperative thrombolytic drugs (16 studies, 184 flaps), (3) placement of an arteriovenous fistula (5 case reports, 5 flaps), and (4) postoperative medicinal leech therapy (11 studies, 73 flaps)
Comparador
Cross-technique comparison of pooled salvage success rates from heterogeneous studies; only 5 studies provided comparative control-group data
Punto final primario
Flap salvage success rate across published techniques; identification of methodological strengths and limitations in flap salvage literature
Resultado primario
Pooled flap salvage success rates were broadly comparable across all four techniques with no single approach demonstrating clear superiority over the others; total reported sample limited to 330 flaps across 39 studies; only 5 of 39 included studies had control groups; level of evidence was uniformly low; the authors concluded that no superior salvage technique was identifiable from the existing evidence base
Duración del seguimiento
follow-up varied by included study (most reported acute postoperative flap status only)

Hallazgos clave

  • Largest pooled flap salvage systematic review at time of publication (39 studies, 330 flaps, 1990-2015)
  • Leech therapy was 1 of 4 main salvage techniques and contributed 11 studies / 73 flaps to the dataset
  • No salvage technique demonstrated clear superiority — emphasizes that leech therapy is a reasonable, evidence-supported option among several
  • Only 5 of 39 studies had control groups, exposing the methodological weakness of the salvage literature
  • Provides the strongest published basis for treating individual salvage technique selection as case-specific rather than algorithm-driven

Limitaciones

  • Pooled descriptive analysis only — no quantitative meta-analysis due to study heterogeneity
  • Underlying studies overwhelmingly low-quality with small samples and missing control groups
  • Publication and reporting bias likely (successful salvage cases over-represented)
  • Inclusion period ends in 2015 — does not capture more recent leech-therapy literature (Lehnhardt 2021, Merlino 2020)
  • Outcome adjudication varied widely across included studies

Implicaciones clínicas

Troeltzsch 2016 is the definitive evidence-quality assessment of the flap-salvage literature through 2015 and concludes that the current published evidence cannot identify a superior salvage technique. For US clinicians, the review reinforces that medicinal leech therapy is one of the four established salvage options (alongside Fogarty thrombectomy, intraoperative thrombolytics, and arteriovenous fistula placement) and that local institutional expertise, patient-specific factors, and technique availability should drive case-by-case decisions. The review is also commonly cited to justify continued use of leech therapy as a legitimate K040187 technique pending higher-quality comparative trials.

Estudios relacionados

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.